Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

Vesna Ivanovic; Arnold Melman; Brian Davis-Joseph; Mira Valcic; Jan Geliebter

doi:10.1038/nm0495-282

Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

Vesna Ivanovic, Arnold Melman, Brian Davis-Joseph, Mira Valcic, Jan Geliebter

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	282-284
Number of pages	3
Journal	Nature Medicine
Volume	1
Issue number	4
DOIs	https://doi.org/10.1038/nm0495-282
State	Published - Apr 1995
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nm0495-282

Cite this

@article{4e5020ae11b048b9b32cdc8249cb7abd,

title = "Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer",

author = "Vesna Ivanovic and Arnold Melman and Brian Davis-Joseph and Mira Valcic and Jan Geliebter",

year = "1995",

month = apr,

doi = "10.1038/nm0495-282",

language = "English (US)",

volume = "1",

pages = "282--284",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

AU - Ivanovic, Vesna

AU - Melman, Arnold

AU - Davis-Joseph, Brian

AU - Valcic, Mira

AU - Geliebter, Jan

PY - 1995/4

Y1 - 1995/4

UR - http://www.scopus.com/inward/record.url?scp=0028902318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028902318&partnerID=8YFLogxK

U2 - 10.1038/nm0495-282

DO - 10.1038/nm0495-282

M3 - Letter

C2 - 7585049

AN - SCOPUS:0028902318

SN - 1078-8956

VL - 1

SP - 282

EP - 284

JO - Nature Medicine

JF - Nature Medicine

IS - 4

ER -

Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this